ClinicalTrials.gov record
Terminated Phase 2 Interventional

Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer

ClinicalTrials.gov ID: NCT00003179

Public ClinicalTrials.gov record NCT00003179. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 10:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Two-Part Study of the Treatment of Atypical Endometrial Hyperplasia: Part A: A Prospective Study of Immediate Hysterectomy; Part B: A Randomized Phase II Study of Medroxyprogesterone Acetate Versus Depoprovera

Study identification

NCT ID
NCT00003179
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
360 participants

Conditions and interventions

Interventions

  • medroxyprogesterone Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 1998
Primary completion
Jan 31, 2006
Completion
Not listed
Last update posted
Jun 9, 2013

Started 1998

United States locations

U.S. sites
30
U.S. states
21
U.S. cities
29
Facility City State ZIP Site status
Arizona Cancer Center Tucson Arizona 85724-5024
Community Hospital of Los Gatos Los Gatos California 95032
Chao Family Comprehensive Cancer Center Orange California 92868
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5001
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Indiana University Cancer Center Indianapolis Indiana 46202-5289
Holden Comprehensive Cancer Center Iowa City Iowa 52242-1009
Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky 40536-0084
Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore Maryland 21201
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21231-2410
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda Maryland 20892-1182
University of Mississippi Medical Center Jackson Mississippi 39216-4505
Keesler Medical Center - Keesler AFB Keesler Air Force Base Mississippi 39534-2576
Ellis Fischel Cancer Center - Columbia Columbia Missouri 65203
Washington University School of Medicine St Louis Missouri 63110
Cooper Hospital/University Medical Center Camden New Jersey 08103-1489
State University of New York Health Sciences Center - Stony Brook Stony Brook New York 11794-8091
Duke Comprehensive Cancer Center Durham North Carolina 27710
Comprehensive Cancer Center at Wake Forest University Winston-Salem North Carolina 27157-1065
Barrett Cancer Center Cincinnati Ohio 45267-0526
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
Arthur G. James Cancer Hospital - Ohio State University Columbus Ohio 43210-1240
University of Oklahoma College of Medicine Oklahoma City Oklahoma 73190
Abington Memorial Hospital Abington Pennsylvania 19001-3788
Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850
Medical University of South Carolina Charleston South Carolina 29425-2233
Brookview Research, Inc. Nashville Tennessee 37203
University of Texas Medical Branch Galveston Texas 77555-0587
Fletcher Allen Health Care - Medical Center Campus Burlington Vermont 05401
Cancer Center at the University of Virginia Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003179, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 9, 2013 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00003179 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →